215 related articles for article (PubMed ID: 12363043)
21. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
22. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
Muenchen HJ; Poncza PJ; Pienta KJ
Urology; 2001 Feb; 57(2):366-70. PubMed ID: 11182366
[TBL] [Abstract][Full Text] [Related]
23. [Antisense RNA of survivin gene enhances the taxol-induced apoptosis and sensitivity to chemotherapy drugs in bladder cancer cells: an in vitro experiment].
Wang ZH; Ye Q; Huang DY; Hu ZQ; Ye ZQ; Yang N; Liu H; Zhuang QY; Yang WM; Liu JH; Zhang X
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):419-22. PubMed ID: 17456386
[TBL] [Abstract][Full Text] [Related]
24. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel.
Kar R; Palanichamy JK; Banerjee A; Chattopadhyay P; Jain SK; Singh N
Clin Transl Oncol; 2015 Sep; 17(9):737-42. PubMed ID: 26033427
[TBL] [Abstract][Full Text] [Related]
25. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
[TBL] [Abstract][Full Text] [Related]
26. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
[TBL] [Abstract][Full Text] [Related]
28. [Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells].
Wang TT; Wei J; Qian XP; Yu LX; Liu BR
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):573-7. PubMed ID: 19102932
[TBL] [Abstract][Full Text] [Related]
29. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
Rosenblum MD; Shivers RR
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
[TBL] [Abstract][Full Text] [Related]
30. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
[TBL] [Abstract][Full Text] [Related]
31. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
Tirrò E; Consoli ML; Massimino M; Manzella L; Frasca F; Sciacca L; Vicari L; Stassi G; Messina L; Messina A; Vigneri P
Cancer Res; 2006 Apr; 66(8):4263-72. PubMed ID: 16618750
[TBL] [Abstract][Full Text] [Related]
33. Cancer gene therapy using a survivin mutant adenovirus.
Mesri M; Wall NR; Li J; Kim RW; Altieri DC
J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of taxol in human head and neck tumors.
Gan Y; Wientjes MG; Schuller DE; Au JL
Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
Tang J; Cao L; Yi H; Tang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375
[TBL] [Abstract][Full Text] [Related]
36. Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.
Makhija S; Taylor DD; Gibb RK; Gerçel-Taylor C
Int J Oncol; 1999 Mar; 14(3):515-21. PubMed ID: 10024685
[TBL] [Abstract][Full Text] [Related]
37. Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis.
Li W; Wang X; Lei P; Ye Q; Zhu H; Zhang Y; Shao J; Yang J; Shen G
J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):1-5. PubMed ID: 18278445
[TBL] [Abstract][Full Text] [Related]
38. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
39. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
40. A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.
Cassinelli G; Supino R; Perego P; Polizzi D; Lanzi C; Pratesi G; Zunino F
Int J Cancer; 2001 Jun; 92(5):738-47. PubMed ID: 11340581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
